Week In Review: AIM Vaccine Stages $20 Million IPO On Hong Kong Exchange

Beijing AIM Vaccine conducted a very small IPO on the Hong Kong exchange, raising just $20 million, which netted the company only $10 million. Interest in the offering was low, with less than 1% of the company shares sold in the offering.